News

Demonstrating Excellence in Outcomes and Culture

Fabhalta (iptacopan) Now Available from Onco360 as the First FDA-Approved Oral Monotherapy Approved for the Treatment of Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH)

News

Stay up to date with the latest innovations, company updates, and industry insights as we work to advance health and wellness for all.